Who
James Rodberg
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Sight Sciences.
In numbers
- Trades disclosed
- 17
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $322K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Mar 2023
- Last trade
- 2 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Dec 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 5 Oct 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $64K7,208 at $8.85 | filing |
| 2 Jul 2026filed 6 Jul 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $37K6,902 at $5.36 | filing |
| 2 Jul 2026filed 6 Jul 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $37K6,902 at $5.36 | filing |
| 6 Apr 2026filed 9 Apr 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $26K7,231 at $3.55 | filing |
| 6 Apr 2026filed 9 Apr 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $26K7,231 at $3.55 | filing |
| 3 Feb 2026filed 5 Feb 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code A | —86,940 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code A | —86,940 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $17K2,616 at $6.62 | filing |
| 16 Jan 2026filed 21 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $17K2,616 at $6.62 | filing |
| 6 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $4,443594 at $7.48 | filing |
| 6 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $4,443594 at $7.48 | filing |
| 5 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $34K4,405 at $7.82 | filing |
| 5 Jan 2026filed 6 Jan 2026 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $34K4,405 at $7.82 | filing |
| 2 Dec 2025filed 3 Dec 2025 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Sold | $21K2,518 at $8.25 | filing |
| 11 Nov 2025filed 13 Nov 2025 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code A | —15,337 at $0.00 | filing |
| 16 Mar 2023filed 21 Mar 2023 | SGHT Sight Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —14,400 at $0.00 | filing |
| 16 Mar 2023filed 21 Mar 2023 | SGHT Sight SciencesMedical Devices | SEC FORM 4 Code A | —20,600 at $0.00 | filing |
News
Insider Selling: Sight Sciences (NASDAQ:SGHT) CTO Sells $70,562.85 in StockSGHT · themarketsdaily.com · 8 Oct 2026Financial Contrast: Nano-X Imaging (NASDAQ:NNOX) & Sight Sciences (NASDAQ:SGHT)SGHT · themarketsdaily.com · 8 Oct 2026
0 headlines in the last 90 days name James Rodberg; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.